Coumarinic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeability

Citation
Os. Gudmundsson et al., Coumarinic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeability, PHARM RES, 16(1), 1999, pp. 7-15
Citations number
43
Categorie Soggetti
Pharmacology & Toxicology
Journal title
PHARMACEUTICAL RESEARCH
ISSN journal
07248741 → ACNP
Volume
16
Issue
1
Year of publication
1999
Pages
7 - 15
Database
ISI
SICI code
0724-8741(199901)16:1<7:CACPOO>2.0.ZU;2-A
Abstract
Purpose. To evaluate the cellular permeation characteristics and the chemic al and enzymatic stability of coumarinic acid-based cyclic prodrugs (1) und er bar and (2) under bar of the opioid peptides [Leu(5)]-enkephalin (H-Tyr- Gly-Gly-Phe-Leu-OH) and DADLE (H-Tyr-D-Ala-Gly-Phe-D-Leu-OH), respectively. Methods. The rates of conversion of the cyclic prodrugs (1) under bar and ( 2) under bar to [Leu(5)]-enkephalin and DADLE, respectively, in HBSS, pH 7. 4 (Caco-2 cell transport buffer) and in various biological media having mea surable esterase activity were determined by HPLC. The cell permeation char acteristics of [Leu(5)]-enkephalin, DADLE and cyclic prodrugs (1) under bar and (2) under bar were measured using Caco-2 cell monolayers grown onto mi croporus membranes and monitored by HPLC. Results. In HBSS, pH 7.4, cyclic prodrugs (1) under bar and (2) under bar d egraded chemically to intermediates that further degraded to [Leu(5)]-enkep halin and DADLE, respectively, in stoichiometric amounts. In 90% human plas ma and rat liver homogenate, the disappearance of cyclic prodrugs (1) under bar and (2) under bar was significantly faster than in HBSS, pH 7.4. The h alf-lives in 90% human plasma and in rat liver homogenate were substantiall y longer after pretreatment with paraoxon, a known inhibitor of serine-depe ndent esterases. When applied to the AP side of a Caco-2 cell monolayer, cy clic prodrug (1) under bar exhibited significantly greater stability agains t peptidase metabolism than did [Leu(5)]-enkephalin, Cyclic prodrug (2) und er bar and DADLE exhibited similar stability when applied to the AP side of the Caco-2 cell monolayer. Prodrug (1) under bar was 665-fold more able to permeate the Caco-2 cell monolayers than was [Leu(5)]-enkephalin, in part because of its increased enzymatic stability. Prodrug (2) under bar was sho wn to be approximately 31 fold more able to permeate a Caco-2 cell monolaye r than was DADLE. Conclusions. Cyclic prodrugs (1) under bar and (2) under bar, prepared with the coumarinic acid promoiety, were substantially more able to permeate Ca co-2 cell monolayers than were the corresponding opioid peptides. Prodrug ( 1) under bar exhibited increased stability to peptidase metabolism compared to [Leu(5)]-enkephalin. In various biological media, the opioid peptides w ere released from the prodrugs by an esterase-catalyzed reaction, which is sensitive to paraoxon inhibition.